financetom
Business
financetom
/
Business
/
Plus Therapeutics Gets Additional Time to Regain Compliance With Nasdaq Listing Requirement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Plus Therapeutics Gets Additional Time to Regain Compliance With Nasdaq Listing Requirement
Nov 4, 2024 12:17 PM

01:01 PM EDT, 11/01/2024 (MT Newswires) -- Plus Therapeutics ( PSTV ) said in a regulatory filing Friday that a Nasdaq Hearings panel granted it until March 4, 2025 to regain compliance with the exchange's listing requirement for minimum shareholders' equity.

Shares were up over 6% in recent trading.

Price: 1.36, Change: +0.08, Percent Change: +6.56

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gatos Silver Amends Los Gatos JV Agreements With Dowa Metals and Mining
Gatos Silver Amends Los Gatos JV Agreements With Dowa Metals and Mining
Dec 20, 2024
06:38 AM EST, 12/20/2024 (MT Newswires) -- Gatos Silver ( GATO ) late on Thursday said it has amended its joint venture agreements with Dowa Metals and Mining, effective Jan. 1, to expand Gatos' management rights within the Los Gatos joint venture. The amendments allow Gatos to fully consolidate the financial statements of the Los Gatos JV rather than accounting...
Hims & Hers Health Shares Fall on FDA Declaration of End to Tirzepatide Shortage
Hims & Hers Health Shares Fall on FDA Declaration of End to Tirzepatide Shortage
Dec 20, 2024
06:44 AM EST, 12/20/2024 (MT Newswires) -- Hims & Hers Health ( HIMS ) shares were down more than 3.5% in Friday's premarket activity after closing down 7.7% on Thursday following a US Food and Drug Administration determination that a shortage of Eli Lilly's ( LLY ) popular weight loss drug tirzepatide has ended. Hims & Hers Health ( HIMS...
Sidus Space Closes $14.1 Million Capital Raise: Details
Sidus Space Closes $14.1 Million Capital Raise: Details
Dec 20, 2024
Sidus Space, Inc. ( SIDU ) shares are trading lower in the premarket session on Friday. The company revealed it had successfully closed a transaction with accredited and institutional investors, issuing units consisting of shares of Class A common stock (or Pre-funded Warrants in lieu) along with Common Warrants. The offering raised approximately $14.1 million in gross proceeds, before deducting...
Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints
Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints
Dec 20, 2024
* Data wipes $125 billion from Novo's market value * CagriSema is Novo's next-gen obesity drug candidate after Wegovy * Novo had expected weight loss of 25% * Novo exec says 'encouraged' by data By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN, Dec 20(Reuters) - Novo Nordisk said on Friday its experimental next-generation obesity drug CagriSema helped patients cut their weight...
Copyright 2023-2026 - www.financetom.com All Rights Reserved